MedTrace Logo

Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation

NCT04094844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2026-04-14

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).

Conditions

Interventions

OTHER

Wearable activity sensor

Caregivers and patients in both arms of the study will have a Fitbit wearable activity sensor to track activity and sleep.

BEHAVIORAL

Roadmap 2.0 information system

Caregivers and patients download the Roadmap 2.0 app on their mobile phones or tablets

OTHER

Survey administration

Caregivers and patients will be asked to respond to survey questions at 3 timepoints.

BEHAVIORAL

Roadmap 2.0 information system with Positive Activities

Caregivers and patients download the Roadmap 2.0 app on their mobile phones. Caregivers and patients will be instructed on how to operate Roadmap 1.0 on an iPad (inpatient only) and Roadmap 2.0 on a mobile phone (inpatient and outpatient). Caregivers download the Positive Activities app onto their mobile phone to use freely throughout inpatient and outpatient (through day 120 post-transplant). Caregiver may also use an electronic tablet provided by the study team during the patient's hospital stay.

Sponsors & Collaborators

Principal Investigators

  • Sung Won Choi, MD, MS · University of Michigan Rogel Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-08
Primary Completion
2024-08-11
Completion
2024-08-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04094844 on ClinicalTrials.gov